Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Therapeutic Advances in Medical Oncology
|
January 22, 2024
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry
Bruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca, et al.
Microorganisms
|
April 27, 2024
<i>Pseudomonas aeruginosa</i> Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy
Cristina Royo-Cebrecos, Júlia Laporte-Amargós, Marta Peña, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 29, 2023
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry
Anahita Mostaghim, Samuel Minkove, Juan Aguilar-Company, et al.
Pathogens (Basel, Switzerland)
|
October 27, 2022
<i>Pseudomonas aeruginosa</i> Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors
Cristina Royo-Cebrecos, Julia Laporte-Amargós, Marta Peña, et al.
Cancers
|
July 12, 2020
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
David J Pinato, Alvin J X Lee, Federica Biello, et al.
Therapeutic Advances in Medical Oncology
|
September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Gehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
Microorganisms
|
April 23, 2022
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with <i>Pseudomonas aeruginosa</i> Pneumonia
Adaia Albasanz-Puig, Xavier Durà-Miralles, Júlia Laporte-Amargós, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2022
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer
David J Pinato, Daniela Ferrante, Juan Aguilar-Company, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
Journal for Immunotherapy of Cancer
|
March 23, 2021
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
Gino M Dettorre, Saoirse Dolly, Angela Loizidou, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Therapeutic Advances in Medical Oncology
|
January 22, 2024
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry
Bruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca, et al.
Microorganisms
|
April 27, 2024
<i>Pseudomonas aeruginosa</i> Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy
Cristina Royo-Cebrecos, Júlia Laporte-Amargós, Marta Peña, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 29, 2023
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry
Anahita Mostaghim, Samuel Minkove, Juan Aguilar-Company, et al.
Pathogens (Basel, Switzerland)
|
October 27, 2022
<i>Pseudomonas aeruginosa</i> Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors
Cristina Royo-Cebrecos, Julia Laporte-Amargós, Marta Peña, et al.
Cancers
|
July 12, 2020
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
David J Pinato, Alvin J X Lee, Federica Biello, et al.
Therapeutic Advances in Medical Oncology
|
September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Gehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
Microorganisms
|
April 23, 2022
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with <i>Pseudomonas aeruginosa</i> Pneumonia
Adaia Albasanz-Puig, Xavier Durà-Miralles, Júlia Laporte-Amargós, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2022
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer
David J Pinato, Daniela Ferrante, Juan Aguilar-Company, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
Journal for Immunotherapy of Cancer
|
March 23, 2021
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
Gino M Dettorre, Saoirse Dolly, Angela Loizidou, et al.
Page
of 8